Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections
The Journal of Infectious Diseases · 15.04.2025 · 231 (4) · 913-920
DOI: 10.1093/infdis/jiae496 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 09.10.2024. Verfasst von Kristyn Langworthy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Fiona Stanley Fremantle Hospitals Group, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcal Vaccines, Antibodies, Bacterial, Antigens, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Australian Government, University of Western Australia.
Abstract (Originalsprache)
Background
Rising incidence of invasive β-hemolytic streptococcal (iBHS) infections has prompted consideration of vaccination as a preventative strategy for at-risk populations. The benefits of a vaccine targeting Lancefield group A (Streptococcus pyogenes; Strep A) would increase if cross-species immunity against Lancefield groups C/G (Streptococcus dysgalactiae subspecies equisimilis; SDSE) and B (Streptococcus agalactiae; GBS) was demonstrated.
Methods
A prospective, observational study of adult patients with iBHS infections due to Strep A, SDSE, or GBS. Antibody responses to 6 Strep A candidate antigens were assayed on acute and convalescent sera. A serological response was defined as an increase of >0.2 log10 arbitrary units/mL (AU/mL).
Results
Sixty-seven participants were enrolled. Thirty-three participants were included in the final analysis (12, 11, and 10 with Strep A, SDSE, and GBS, respectively). The median serological response for participants with Strep A was significant for all tested antigens (median >0.2 log10 difference between acute and convalescent samples; P < .05 for all). Those with SDSE had comparable and significant median responses to streptolysin-O (0.65 log10 AU/mL; interquartile range [IQR], 0.36–1.67; P = .004), S. pyogenes adhesion and division protein (0.68 log10 AU/mL; IQR, 0.36–1.63; P = .005), and C5a peptidase (ScpA; 0.30 log10 AU/mL; IQR, 0.23–1.06; P = .004). GBS responses were limited to ScpA only (0.34 log10 AU/mL; IQR, 0.08–0.52; P = .05).
Conclusions
Patients with invasive Strep A infection mount robust antibody responses to 6 non-M protein vaccine candidate antigens. Similar significant responses to C5a peptidase in those with invasive SDSE and GBS infection highlight the importance of further research into cross-species protection and immunological correlates of vaccine efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Fiona Stanley Fremantle Hospitals Group, Murdoch, Western Australia, Australia.
- General Medicine Department, Rockingham General Hospital, Cooloongup, Western Australia, Australia.
- School of Biomedical Science, Faculty of Health and Medical Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
- Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
- Faculty of Health Sciences, Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
- Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: Kristyn Langworthy, Michael Taggart, Rosemary Smith, Avram Levy, Daniel R Knight, Siong Hui, Alma Fulurija, Michael Morici, Edward Raby, Laurens Manning
Förderung
- Australian Government
- University of Western Australia
Zitieren
APA
Langworthy, K., Taggart, M., Smith, R., Levy, A., Knight, D. R., Hui, S., Fulurija, A., Morici, M., Raby, E., & Manning, L. (2025). Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections. The Journal of Infectious Diseases, 231(4), 913-920. https://doi.org/10.1093/infdis/jiae496
Vancouver
Langworthy K, Taggart M, Smith R, Levy A, Knight DR, Hui S, et al. Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections. The Journal of Infectious Diseases. 2025;231(4):913-920. doi:10.1093/infdis/jiae496
BibTeX
@article{Langworthy2025,
author = {Langworthy, Kristyn and Taggart, Michael and Smith, Rosemary and Levy, Avram and Knight, Daniel R and Hui, Siong and Fulurija, Alma and Morici, Michael and Raby, Edward and Manning, Laurens},
title = {Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {4},
pages = {913--920},
doi = {10.1093/infdis/jiae496}
}
EUVIMED